Skip to content
10-Q

Quarterly Report

MANHATTAN SCIENTIFICS, INC.

0001477932-24-005089

← back to feed
Filed
Aug 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 19, 2024 559.28M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$59K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$139K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$3.4M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$3.24M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$2.86M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$2.34M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$2.12M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$1.7M
Current Liabilities Q2 2024 · Jun 30, 2024 $2.42M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.12M
Total Liabilities Q2 2024 · Jun 30, 2024 $2.42M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.12M
Current Assets Q2 2024 · Jun 30, 2024 $45K
Current Assets Q2 2024 · Dec 31, 2023 $69K
Total Assets Q2 2024 · Jun 30, 2024 $74K
Total Assets Q2 2024 · Dec 31, 2023 $316K
Eps Diluted Q2 2024 · Jun 30, 2024 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2024 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2024 $158K
Sga Expense Q2 2024 · Jun 30, 2024 $347K
Sga Expense Q2 2024 · Jun 30, 2023 $181K
Sga Expense Q2 2024 · Jun 30, 2023 $367K
Rd Expense Q2 2024 · Jun 30, 2024 $2K
Rd Expense Q2 2024 · Jun 30, 2024 $5K
Rd Expense Q2 2024 · Jun 30, 2023 $5K
Rd Expense Q2 2024 · Jun 30, 2023 $5K
Net Income Q2 2024 · Jun 30, 2024 −$158K
Net Income Q2 2024 · Jun 30, 2024 −$540K
Net Income Q2 2024 · Mar 31, 2024 −$382K
Net Income Q2 2024 · Jun 30, 2023 −$229K
Net Income Q2 2024 · Jun 30, 2023 −$649K
Net Income Q2 2024 · Mar 31, 2023 −$420K
Operating Income Q2 2024 · Jun 30, 2024 −$160K
Operating Income Q2 2024 · Jun 30, 2024 −$352K
Operating Income Q2 2024 · Jun 30, 2023 −$186K
Operating Income Q2 2024 · Jun 30, 2023 −$372K
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2023 $0
Revenue Q2 2024 · Jun 30, 2023 $0